Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline - Wikidata - wikimedia - TriplyDB

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

http://www.wikidata.org/entity/Q24608464

about

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)Lipids in liver transplant recipients Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus Origin and therapy for hypertriglyceridaemia in type 2 diabetes Aggravation of hypertriglyceridemia and acute pancreatitis in a bipolar patient treated with quetiapine Severe gestational hypertriglyceridemia: A practical approach for clinicians Severe/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original Findings Overview of prescription omega-3 fatty acid products for hypertriglyceridemia Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster Olive oil and postprandial hyperlipidemia: implications for atherosclerosis and metabolic syndrome.Hypertriglyceridemia: the importance of identifying patients at risk.Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System.Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Therapy of Canine Hyperlipidemia with Bezafibrate Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol.Stratified analysis and clinical significance of elevated serum triglyceride levels in early acute pancreatitis: a retrospective study.Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease Effects of aerobic exercise on lipids and lipoproteins Emphysematous pancreatitis predisposed by Olanzapine.Acute Pancreatitis Secondary to Severe Hypertriglyceridemia: Management of Severe Hypertriglyceridemia in Emergency Setting Statins and their role in acute pancreatitis: Case report and literature review.Effect of icosapent ethyl (eicosapentaenoic acid ethyl ester) on omeprazole plasma pharmacokinetics in healthy adults.Nanopharmaceuticals (part 1): products on the market.Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia.Effect of concomitant icosapent ethyl (eicosapentaenoic acid ethyl ester) on the pharmacokinetics of atorvastatin.Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice Acute Pancreatitis and Splenic Vein Thrombosis due to Hypertriglyceridemia.Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.Psychological impact of lifestyle-related disease disclosure at general checkup: a prospective cohort study.Is the endocrine research pipeline broken? A systematic evaluation of the Endocrine Society clinical practice guidelines and trial registration.Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent Ethyl

P2860

Q26738554-63293D86-9A72-484B-83DC-F920091E8F5D Q26745946-7D2E0051-178F-42F0-B1D1-1DD88B8B8DB4 Q26747559-C7CC4B17-67B6-4B7B-BE47-513C925EA285 Q26750468-63BCCCD8-35F5-4FDD-9EDF-891D774E7D6B Q26752919-CCAACA8F-89F2-4ADF-8603-977FC0D5A8B5 Q26824004-BC6168AE-FEBA-4898-9593-0DBFDF66E9A2 Q26851259-A7F21F10-0519-41E4-B266-73972597E6EC Q28074676-FC1CB759-6F1E-40E4-B198-E22A233F2FC6 Q28082905-8291D4A9-EA5B-4AFE-937E-40D621A76561 Q28251391-A991B1E1-8EC2-4206-B8D4-9F6697B3165D Q28538170-0FDC98FA-7BA8-4949-B146-9281F7BB20BB Q30240705-44F58ED9-F974-474A-8326-B31CA32A5E39 Q30244825-F3909B31-5185-4E13-915D-E5AFFB9EB767 Q31133235-5432D7A9-0607-4895-8F7B-D783A2D01C82 Q31157018-2C9984B8-45F2-496B-AACA-BC70F141AD80 Q33632381-E5228851-4BD4-423F-A237-7EDE722B4320 Q33639909-8A876B1F-3FA6-4753-A644-EF05A6140B11 Q33698528-2B627963-4B4A-45D9-B75A-462079F3BDA3 Q33724722-3BF7F65D-4908-4615-832B-5D9938B123E9 Q33846650-CA1D51A9-2D5A-40D2-A586-CAB5236F07AA Q33855092-D1BC9258-A64D-4AF7-B132-659428721616 Q33876773-1F51E4E8-A140-4BB8-A8AC-30060D76320C Q33878360-B54511CA-7D60-46DF-85CD-028A9C92EA2E Q33893869-1880647B-79A6-4C04-A364-1A62CC568230 Q34047683-287A3A26-54F4-4DE5-9619-2E29BD537335 Q34130383-89C00116-23EC-48BA-A639-09B980A92E5B Q34230175-545E84B2-CA0B-41D9-8DA3-2660B195C2B6 Q34267235-18597B40-A76E-4EED-B7BF-D30DD6A39677 Q34357562-395E20D8-34A8-4AE7-A5B5-B295CDB441E7 Q34359967-F0B3FD9D-D02F-42EE-9519-7E7253BD10C7 Q34439420-EDFC7EF9-78C3-4B9A-A563-73C1ED3CCD21 Q34451932-B245E796-FBBB-416B-9FDD-2BEB9D502CE5 Q34687470-B27A5F62-FDD0-426D-AED2-55A00B2CC6A6 Q34946523-43A81182-56C6-4A25-AA1D-A8636B361233 Q35156758-C8D1D5B1-D6E0-45C1-9834-26D9373099FD Q35335896-784F7537-A9D9-4A1A-9B88-57D1565D8C74 Q35460381-6B7095DF-FCE4-4FEF-BEB8-C10B9AA563FD Q35624460-7D22E89E-C6B9-4699-A6D8-CBE7E7C70732 Q35743293-4F1B5AE2-EAAF-4501-A623-062F38DD0B70 Q35756633-D4E520BF-1FEA-4E5B-9DB9-4177D89EA959

P2860

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

http://www.wikidata.org/entity/Q24608464

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Evaluation and treatment of hy ...... ty clinical practice guideline

@ast

Evaluation and treatment of hy ...... ty clinical practice guideline

@en

Evaluation and treatment of hy ...... ty clinical practice guideline

@nl

type

label

Evaluation and treatment of hy ...... ty clinical practice guideline

@ast

Evaluation and treatment of hy ...... ty clinical practice guideline

@en

Evaluation and treatment of hy ...... ty clinical practice guideline

@nl

prefLabel

Evaluation and treatment of hy ...... ty clinical practice guideline

@ast

Evaluation and treatment of hy ...... ty clinical practice guideline

@en

Evaluation and treatment of hy ...... ty clinical practice guideline

@nl

P1433

Q24608464-32A131C3-D542-470B-9137-4FC5D6C37462

P1476

Q24608464-02E1332D-DA9B-402F-9DD8-7B88DAB6E1E5

P2093

Q24608464-1AC650C8-4650-4546-B96C-70B57C02A1F8

Q24608464-62E8EB0B-A868-4476-A73D-7FFECDCB88A4

Q24608464-863BC729-4F04-4A3E-84CB-835ADE7FA066

Q24608464-A6531733-5D87-4E77-B371-5DC47C1E37CD

Q24608464-F1FCB453-84C9-4CBE-B10A-863BF3729B7F

P2860

Q24608464-00BE12A3-18D4-4D9B-85E5-A160EE4B8D2D

Q24608464-0201A6BF-6FAE-475A-9F26-3EC27E92C535

Q24608464-0280FB59-1699-4543-9AE1-4C27C5A0D85B

Q24608464-03E86C58-EEC4-4F8F-8F00-391847D18B96

Q24608464-04F84509-0CF9-4366-916B-AB6F601B58A1

Q24608464-058FCE44-B62F-41C7-8DB3-4FDEB54B8E04

Q24608464-0602DF8B-C101-4F79-8055-5AE5AEB05F0B

Q24608464-062498B2-A294-4815-9A5E-C8E948312CE1

Q24608464-099F4BEE-BEA1-47AC-AA5F-84CB403ED75F

Q24608464-0DA922E0-64D6-4C99-9A0B-09E0F188EFB4

P304

Q24608464-883D7E46-9816-427F-AB2E-CD041B03CF98

P31

Q24608464-48551D90-F963-49C5-8728-145A88D053B8

P3181

Q24608464-ECABF476-A402-4630-956F-CC37127DE191

P356

Q24608464-D02B4464-A03F-4F3E-A1D6-5BC6C605F2FA

P407

Q24608464-67F6641E-99CF-4986-AA7B-F6AABFF1779A

P433

Q24608464-95986005-F101-4BB7-BCDA-957E60E96158

P478

Q24608464-3D2BEF3E-8B40-4FB2-BB1A-1E34E49DED51

P50

Q24608464-171871EE-29F3-4221-905E-F0F4F8BB7499

Q24608464-CE63A0EA-9968-4E5B-9CEF-57A2DAB1BEE4

P577

Q24608464-89E19065-DF69-48FE-8BB5-EE563E9D9F7D

P5875

Q24608464-1261F469-AC80-42E7-8039-9661C4948332

P698

Q24608464-C02422DC-0F1B-4639-BCE4-53F674155283

P932

Q24608464-38AAF28E-6E2B-4FED-BF83-1183277BA241

P3181

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Evaluation and treatment of hy ...... ty clinical practice guideline

@en

P2093

Anne C Goldberg

http://www.w3.org/2001/XMLSchema#string

Anton F H Stalenhoef

http://www.w3.org/2001/XMLSchema#string

Frank Sacks

http://www.w3.org/2001/XMLSchema#string

Ira J Goldberg

http://www.w3.org/2001/XMLSchema#string

John D Brunzell

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Grading quality of evidence and strength of recommendations

Triglycerides as vascular risk factors: new epidemiologic insights

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

The mysteries of lipoprotein(a)

P304

2969-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

22180

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/JC.2011-3213

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad H. Murad

Lars F. Berglund

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230827372

http://www.w3.org/2001/XMLSchema#string

P698

22962670

http://www.w3.org/2001/XMLSchema#string

P932

3431581

http://www.w3.org/2001/XMLSchema#string